Identification and Validation of a Novel Immune-Related Four-lncRNA Signature for Lung Adenocarcinoma
Lung adenocarcinoma (LUAD) is a major subtype of lung cancer, the prognosis of patients with which is associated with both lncRNAs and cancer immunity. In this study, we collected gene expression data of 585 LUAD patients from The Cancer Genome Atlas (TCGA) database and 605 subjects from the Gene Ex...
Main Authors: | Jixin Wang, Xiangjun Yin, Yin-Qiang Zhang, Xuming Ji |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-02-01
|
Series: | Frontiers in Genetics |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fgene.2021.639254/full |
Similar Items
-
Identification and Validation of Immune-Related LncRNA Prognostic Signature for Lung Adenocarcinoma
by: Guomin Wu, et al.
Published: (2021-07-01) -
Identification of 4 immune cells and a 5-lncRNA risk signature with prognosis for early-stage lung adenocarcinoma
by: Lan Mu, et al.
Published: (2021-03-01) -
Characterization of a ferroptosis and iron-metabolism related lncRNA signature in lung adenocarcinoma
by: Jie Yao, et al.
Published: (2021-07-01) -
Six-lncRNA Immune Prognostic Signature for Cervical Cancer
by: Qian Chen, et al.
Published: (2020-10-01) -
Construction of a Novel Lung Adenocarcinoma Immune-Related lncRNA Pair Signature
by: Qi X, et al.
Published: (2021-08-01)